TI16037
TI16126
Best Travel Technology Company - UK
Best eCOA Solution: TrialMax®
Company: Comtec Group Ltd Name: Simon Powell Web Address: www.comtec-group.com Address: 3 The Quadrangle, Vision Court, Cardiff, CF23 8HA
Company: CRF Health Name: John Blakeley Web Address: www. crfhealth.com Address: 4000 Chemical Road, Suite 400, Plymouth Meeting, PA, 19462 Telephone: +1 267 498 2300
CRF Health is a leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry. We invited John Blakeley to tell us more. Comtec is the largest seller of specialist tour operator systems with one of the most recognised and well-known brands in the UK travel technology sector. We invited Simon Powell to provide us with an overview of the firm and the solutions it offers. Internationally, Comtec has customers in Canada, France, Ireland, the Netherlands, Scandinavia, and Croatia. Since 2008, Comtec has invested heavily in penetrating the North American market, and as a result, Comtec has developed a modern, feature rich tour operator system specifically for the overseas markets. As a firm we provide mission critical software and related services to a large and loyal customer base that includes many of the UK’s top 100 tour operators and travel agencies. Our offering includes Travelink, the most widely used specialist tour operator multichannel sales and management system in the UK and Travelconnect, one of the most modern retail travel agency sales systems in the UK. We also offer Personalisation and Content Aggregation via our partnership with sister Company Eysys. These solutions offer the highest level of functional sophistication combined with greatest scalability and reliability in the market coupled with exceptional value for money, a clear understanding of the industry needs, innovation, proven management leadership and a real positive can do attitude to be the best With regards to services, we provide customer relationship management, e-commerce and revenue management tools designed to meet the needs of the business, as well as consultancy, training and development services. Ultimately it is our mission to be the leading provider of Tour Operator and Retail systems on a global basis delivering exceptional client service and long term successful, enjoyable and profitable relationships. We aim to achieve this through exceptional product quality supported by continuous client CSQ and internal KPI management which have established a framework for all to see, aspire too and enjoy. Currently the business is at a very exciting time of accelerated growth and we are excited about what the future holds for the firm. Our partnership with Eysys also delivers further technical innovation to our clients enabling multi-channel distribution on a Global basis with personalisation in the client experience on any device.
Since inception in 2000, CRF Health has grown rapidly to become a global leader in eCOA via the development of next-generation solutions that are now improving the clinical trial experience for patients around the world. John outlines the firm’s experience in this area and how it has helped the company to become the market leading success it is today. “With experience in more than 800 eCOA trials, in 100 languages across 74 countries, our eCOA technology is used in global clinical trials and consistently demonstrates high levels of data accuracy, patient and site compliance, and plays a significant role in patient retention.” “Our ultimate mission is to help life sciences companies bring new medicines to market as quickly and cost-effectively as possible, thereby simplify the path to approval. We do this by combining a collaborative, agile design approach with user-friendly data collection tools, to streamline complex processes and deliver reliable results for superior clinical trial outcomes.” Working in such a competitive industry it is vital that firm’s such as CRF Health differentiate from their competitors, as John highlights. “As one of the first companies to put dedicated eCOA devices in the hands of patients, we continue to lead the industry with a uniquely collaborative design process and a focus on patient experience first and foremost. Our team has unparalleled eCOA expertise and share a common vision and passion for the development of patient-focused technologies which are investigator-friendly.” “In addition, we continually strive to bring our innovative approach to different parts of the clinical trial. For example, we have recently introduced TrialConsent™, a first-of-its-kind eCOA-native electronic informed consent technology for use in clinical trials. While others in the industry offer electronic informed consent solutions, TrialConsent is the only solution to offer a single-platform eConsent and eCOA on the same device, removing the need for any additional technologies to be included in a trial’s design, and significantly reducing the burden and complexity for study teams.” Going forward, John emphasised the firm’s dedication to evolving with the market in order to continue offering the very best solutions to its clients. “With modern technology now firmly embedded in people’s lives across all generations of the population, there is no doubt that the eCOA market will continue to evolve. As a company we will continue to invest in research and development to ensure we create game-changing technology which will ultimately accelerate the process of safely getting new drugs to market.”
86 l CV Technology Innovator Awards 2016